Related by context. All words. (Click for frequent words.) 67 Granulocyte Colony Stimulating Factor 66 subcutaneously administered 66 Factor IX 65 Dynepo 65 Ecallantide 65 Factor VIIa 65 injectable formulation 65 Fc fusion protein 65 Increlex R 65 Fresenius Biotech 65 pegylated 64 chemotherapy induced neutropenia 64 PDE4 inhibitor 64 Zenpep 64 selective modulator 64 Campath ® 64 beta 1a 64 somatostatin analogue 64 pancreatic enzyme replacement 64 SYCREST 63 RhuDex ® 63 HuMax CD4 63 omega interferon 63 hyaluronidase rHuPH# 63 octreotide acetate 63 Pegloticase 63 Firdapse 63 oral prodrug 63 recombinant interferon 63 intranasal formulation 63 intravenous formulations 63 P#X# antagonist 63 liposomal formulation 63 Plicera 63 Civacir 63 Amigal 63 cetuximab Erbitux R 63 Cancidas 63 Archexin 63 Lovaza TM 63 TLR9 agonist 63 proteasome inhibitor 63 RECOTHROM R 63 octreotide 63 MOVIPREP R 63 induced macular edema 63 CDP# 63 novel prodrug 63 orally inhaled 63 topical ophthalmic 63 Zalbin 62 Inhalation Powder 62 HSP# inhibitor 62 Degarelix 62 Febuxostat 62 generation purine nucleoside 62 Ganciclovir 62 oral antiviral 62 MNTX 62 PEG IFN 62 Unit Dose Budesonide 62 Nippon Shinyaku 62 Orally administered 62 subcutaneous formulation 62 Lispro 62 Mipomersen 62 Filgrastim 62 Panzem R NCD 62 Clolar ® 62 JAK inhibitor 62 selective A2A adenosine receptor 62 agonist LABA 62 TELINTRA 62 faropenem 62 metaglidasen 62 ruxolitinib 62 MAXY G# 62 polymerase inhibitor 62 docetaxel Taxotere ® 62 Zorbtive TM 62 XL# anticancer compounds 62 CEQ# 62 volociximab 62 Pharmacokinetics PK 62 long acting muscarinic 62 Astellas Deutschland GmbH 62 GTC recombinant human 62 CD# monoclonal antibody 62 Pafuramidine 62 Octreotide 62 soluble tumor necrosis 62 COLAZAL R 62 ISTODAX 62 saquinavir 62 AEGR 62 peripherally acting 62 Pralatrexate 62 Dalbavancin 62 vapreotide acetate 62 Laquinimod 62 IMiDs 62 OncoGel 62 targeted radiotherapeutic 62 Iluvien ® 61 non nucleoside 61 intravenous AAT 61 TNF Tumor Necrosis Factor 61 successfully commercialize Iluvien 61 anticancer agent 61 Æterna Zentaris 61 EndoTAG 61 urocortin 2 61 antiplatelet agent 61 Sanvar R 61 Plenaxis R 61 Cellegesic 61 Irinotecan 61 Icatibant 61 Japanese Encephalitis Vaccine 61 Erbitux cetuximab 61 Advagraf 61 Lupuzor 61 vidofludimus 61 A1PI 61 acetonide FA 61 factor G CSF 61 SCHWARZ PHARMA 61 PRT# 61 glucokinase activator 61 inhaled formulation 61 SPRYCEL ® 61 Panzem R 61 Firazyr 61 CCR9 antagonist 61 2A receptor agonist 61 MVA BN 61 adenosine A2A 61 Poly ICLC 61 cannabinor 61 YONDELIS 61 bardoxolone 61 Myocet 61 Insegia 61 IV Busulfex 61 MAGE A3 ASCI 61 Silodosin 61 humanized anti 61 Iluvien TM 61 HuMax CD# 61 ADP receptor antagonist 61 small molecule tyrosine 61 Preclinical studies suggest 61 Aflibercept 61 CytoFab 61 SAR# [002] 61 Enzyme Replacement Therapy 61 ESBA# 61 otelixizumab 61 Increlex ® 61 terlipressin 61 recombinant Factor 61 fusion inhibitor 61 Simulect 61 histone deacetylase inhibitor 61 MTP inhibitor 61 diarrhea predominant irritable 61 Bicifadine 61 Peginterferon alfa 2b 61 trospium chloride 61 BIM #A# 61 Copegus ribavirin 61 MAP# 61 Interferon alpha 61 Aviptadil 61 Safinamide 61 PHX# 61 reslizumab 61 Palonosetron 61 Targeted Chemotherapy 61 alefacept 61 prostone 61 topical ocular 61 antibody MAb 61 Onalta 61 Nexavar ® 61 methylnaltrexone 61 Proquin XR 61 CD# antibody [001] 61 Clonicel 61 SinuNase ™ 61 outlicensed 61 LymphoStat B TM 61 Hsp# Inhibitor 61 cinacalcet HCl 61 AAG geldanamycin analog 61 Survivin antagonist 61 FOLOTYN ® 61 Inhalation Solution 61 AERx iDMS 61 ulimorelin 61 Nebido 61 Vidaza azacitidine 61 PEGylated anti 61 Dabigatran etexilate 61 lumiliximab 60 Meets Primary Endpoint 60 Ambrisentan 60 SinuNase TM 60 tiapamil 60 PEGylated Fab fragment 60 antisense drug 60 SPRIX ® 60 WILEX AG 60 Neose 60 alpha 2b 60 Cleviprex TM clevidipine 60 IAP inhibitor 60 Telzir 60 Deferiprone 60 ATL# [001] 60 Receives Orphan Drug Designation 60 nucleoside analog 60 adult chronic ITP 60 Chemokine 60 ceftazidime 60 Pivotal Phase III 60 Increlex TM 60 CYC# 60 Ruconest 60 Saizen R 60 TBC# 60 Retacrit 60 RH1 60 PD LID 60 dasatinib Sprycel 60 ocrelizumab 60 mertansine 60 Tarceva TM 60 Frova ® 60 dihydrochloride 60 Maxy G# 60 Personalized Immunotherapy 60 Exelixis compounds 60 Zavesca r 60 Vilazodone 60 Protexia R 60 rhGH 60 Levoleucovorin 60 CDK inhibitor 60 Clofarabine 60 Allovectin 7 R 60 Davanat 60 Tezampanel 60 liposomal delivery 60 Ciclesonide 60 personalized immunotherapy 60 topical gel formulation 60 Syntonix 60 Japanese Encephalitis vaccine 60 GHRH 60 miconazole Lauriad 60 IRX 2 60 Sapacitabine 60 recombinant human 60 Interferon alfa 60 Vaprisol 60 Inhalation Aerosol 60 G#DT 60 tizanidine hydrochloride short 60 Fodosine 60 drug ISA# 60 Anticalin R 60 Traficet EN 60 atacicept 60 LEUKINE 60 Sandostatin LAR 60 Tostrex 60 XL# XL# 60 mild vasodilator 60 sodium glucose cotransporter 60 ProtAffin 60 chimeric monoclonal antibody 60 oxymorphone ER 60 Apaziquone 60 SEBIVO 60 rThrombin 60 humanized monoclonal 60 Cethromycin 60 XmAb ® 60 xanthine oxidase inhibitor 60 SURFAXIN r 60 somatostatin analogues 60 Xanafide 60 rxRNA 60 Pradefovir 60 Anturol TM 60 EZN 60 Leukine ® 60 TroVax ® 60 ARIKACE ™ 60 inhibitor RG# 60 Vascular Wrap TM 60 cathepsin K inhibitor 60 injectable formulations 60 UPLYSO 60 HCD# [002] 60 Multiple Ascending Dose 60 goserelin 60 StemEx 60 sumatriptan DosePro 60 Capesaris 60 albinterferon alfa 2b 60 Fludara ® 60 Lubiprostone 60 coagulation factor VIIa 60 severe gastroparesis 60 Troxatyl TM 60 TYZEKA 60 Orphan Status 60 developing Bicifadine serotonin 60 Annamycin 60 Golimumab 60 Oncaspar 60 fluoropyrimidine 60 herpetic keratitis 60 diabetic neuropathic pain 60 Sebivo 60 SUTENT ® 60 treat male hypogonadism 60 PGL# 60 Talabostat 60 BENLYSTA ® 60 IMiDs ® compound 60 RhuDex 60 oral proteasome inhibitor 60 ALTU 60 small molecule Hedgehog 60 Ceflatonin R 60 tezampanel 60 Elvitegravir 60 Moxifloxacin 60 methylnaltrexone bromide 59 Argatroban 59 fesoterodine 59 Dacogen injection 59 PSN# [001] 59 Rheoscience 59 lomitapide 59 elvucitabine 59 Raptiva R 59 Thrombin topical Recombinant 59 linaclotide 59 Desmoteplase 59 omacetaxine 59 DPP4 59 Oasmia 59 TRISENOX ® 59 Soliris TM eculizumab 59 adalimumab Humira 59 orally disintegrating 59 inhaled liposomal ciprofloxacin 59 Regeneron Pharma 59 Flutiform TM 59 pradefovir 59 IFN Beta CTP 59 Methylnaltrexone 59 GW# [003] 59 LB# [003] 59 Vidofludimus 59 Proxinium TM 59 interferon gamma 1b 59 ALN TTR# 59 Solasia 59 Evoltra 59 Cetrorelix 59 Mg Uk 59 Plasmin 59 MyVax 59 monoclonal anti 59 orally bioavailable 59 humanized antibody 59 ASONEP 59 ATryn ® 59 Orapred ODT 59 G CSF 59 virus HCV protease inhibitor 59 CTAP# Capsules 59 interleukin IL -# 59 Nanobody 59 Adenuric R 59 Dyloject TM 59 Thrombin 59 BCR ABL inhibitors 59 Ereska 59 PrevOnco 59 incyclinide 59 Somatuline Depot 59 alpha antagonist 59 erlotinib Tarceva R 59 PRTX 59 Preotact R 59 novel VDA molecule 59 Initiates Clinical 59 histamine dihydrochloride 59 R sorafenib tablets 59 Tofacitinib 59 AEG# 59 basiliximab 59 sapropterin dihydrochloride 59 PSN# [002] 59 Urokinase 59 Maribavir 59 ONTAK 59 Bendamustine 59 Oracea ® 59 OvaRex R 59 topical anti infective 59 delta opioid receptor 59 phase IIa clinical 59 alpha interferon 59 teriflunomide 59 proprietary polysaccharide 59 ELND# 59 Sycrest 59 telaprevir VX 59 Orphan Drug Status 59 amphotericin B 59 VEGF inhibitor 59 Enhanze 59 Lenalidomide 59 receptor blocker 59 VISICOL R 59 HuLuc# 59 ATG Fresenius S 59 RECOTHROM ® 59 oral RSD# 59 Invicorp R 59 recombinant fibrinogen 59 Crofelemer 59 Aloxi R 59 novel emulsion formulation 59 BAY #-# 59 opioid receptor antagonist 59 inhaled antibiotic 59 HuMax TAC 59 meropenem 59 NTDDS 59 MKC# 59 Amrubicin 59 Ramoplanin 59 Novartis NVS Snapshot Report 59 ALN HPN 59 BARACLUDE R 59 LUVENIQ 59 tyrosine kinase inhibitor TKI 59 DPP4 inhibitor 59 ONCASPAR 59 Pyridorin 59 orally dosed 59 PEG INTRON 59 LEVADEX ™ 59 Azacitidine 59 DPX Survivac 59 Aptivus ® 59 Ofatumumab 59 Mimpara 59 Somatuline R Autogel R 59 Chemophase 59 Axiogenesis 59 gonadotropin releasing hormone GnRH 59 bendamustine 59 Lixivaptan 59 Viramidine 59 Pimavanserin 59 Soliris eculizumab 59 Exherin 59 investigational therapies 59 Kahalalide F 59 Nuron Biotech 59 Romiplostim 59 neuraminidase inhibitor 59 Gamunex C 59 Anticalins R 59 Angiox 59 dutogliptin 59 orally administered inhibitor 59 INCB# [002] 59 CCX# 59 Immunotherapeutic 59 Noxafil 59 Elotuzumab 59 Enhanze Technology 59 Plecanatide 59 orBec 59 Genentech Rituxan 59 eniluracil 59 Rapinyl 59 beta interferons 59 Betaferon R 59 CCX# B 59 YONDELIS R 59 Frova R 59 REMINYL ® 59 human C1 inhibitor 59 rNAPc2 59 phase IIb clinical 59 Forsteo 59 CXA 59 Neulasta ® 59 investigational humanized monoclonal antibody 59 Sublinox 59 Cx# [002] 59 Entocort 59 Posidur 59 Ocrelizumab 59 pan HDAC inhibitor 59 epoetin beta 59 Onconase 59 Receives Marketing Authorization 59 partial agonist 59 Daclizumab 59 Clevudine 59 samalizumab 59 plasmid encoding 59 thymidylate synthase TS 59 Copegus ® 59 Kuvan R 59 Idera Pharmaceuticals 59 synthetic retinoid 59 Zerenex 58 JAK inhibitors 58 oncolytic virus therapies 58 XIAFLEX ® 58 MAXY alpha 58 Shigamabs ® 58 Alvesco R 58 granisetron 58 thetreatment 58 TRISENOX R 58 Dasatinib 58 rhFVIIa 58 Vfend 58 PKC# 58 E1 INT TM 58 RTP #i 58 NEBIDO 58 Valtropin 58 Cinquil 58 kidney urologic 58 acting muscarinic antagonist 58 Combidex 58 Guanilib 58 Resten NG 58 relapsed multiple myeloma 58 TRACON Pharmaceuticals 58 prokinetic agent 58 Ziopharm 58 GLP toxicology studies 58 Rotigotine 58 triphendiol 58 novel synthetic PEGylated 58 GPR# agonist 58 IL# PE#QQR 58 Recombinant Human 58 CytoFabTM 58 Auxilium Pharma 58 levocetirizine 58 HQK 58 Trofex 58 peptidic compound 58 histone deacetylase HDAC inhibitor 58 PDE# inhibitors 58 Pemetrexed 58 Rebif ® 58 Interferon beta 58 intravenously administered 58 Pegylated 58 HepeX B 58 Allovectin 7 58 Initiates Phase II 58 trospium 58 SAR# [004] 58 Veregen TM 58 Agenerase 58 ILUVIEN ® 58 Loramyc 58 oral taxane 58 Telatinib 58 Locked Nucleic Acid LNA 58 Mg Usa 58 AcelRx 58 lucinactant 58 IMiD 58 Fast Track Status 58 systemic immunosuppressive drugs 58 topical formulations 58 VAPRISOL 58 oral Hsp# inhibitor 58 effector function 58 MKC# MT 58 Preotact 58 Urocidin 58 Trobalt 58 Phase IIb clinical trials 58 Aerosurf 58 Darunavir 58 Cefixime 58 Carvedilol 58 BCR ABL inhibitor 58 Loramyc R 58 Sanctura XR 58 TKB# 58 sorafenib Nexavar 58 topically administered 58 Therapeutic Competitors Companies 58 Lodotra 58 Lumacan 58 elotuzumab 58 RhuDex R 58 BioGeneriX 58 SERMs 58 ALKS 58 darifenacin 58 #D#C# 58 TNF inhibitor 58 humanised monoclonal antibody 58 HYLENEX recombinant 58 AVONEX ® 58 factor Xa inhibitor 58 Anidulafungin 58 INSPIRE Trial Phase III 58 Nascobal 58 thymalfasin 58 immunotherapeutic vaccine 58 Removab 58 tranilast 58 LUCASSIN 58 Pennsaid R 58 Pirfenidone 58 delivers fluocinolone acetonide FA 58 ® bortezomib 58 rilpivirine 58 Specifid 58 Abiraterone acetate 58 erlotinib Tarceva ® 58 Rebif interferon beta 1a 58 TRX1 58 Vernakalant 58 selective adenosine 58 BEMA TM Fentanyl 58 thrombopoietin 58 ZADAXIN ® 58 targeting CD# 58 ProFibrix 58 Vascular Disrupting Agent 58 oncology indications 58 Pfizer Sutent 58 dasatinib Sprycel ® 58 Opterone R 58 Marketing Authorisation Application 58 TMC# [002] 58 MUSE ® 58 PEG SN# 58 eprotirome 58 rhMBL 58 hyaluronidase enzyme 58 Luteinizing Hormone Releasing Hormone 58 mu opioid receptor antagonist 58 nasal formulation 58 rusalatide acetate 58 Navelbine ® 58 Medigene 58 JAK1 58 PNP inhibitor 58 PDX pralatrexate 58 rasagiline tablets 58 MKC# MKC# PP 58 CYT# potent vascular disrupting 58 epoetin delta 58 Corlux 58 erythropoiesis stimulating agent 58 SARMs 58 Pazopanib 58 IX Fc fusion 58 WILEX 58 BRILINTA 58 highly selective inhibitor 58 desvenlafaxine 58 synthetic siRNA 58 Joulferon 58 Forodesine HCl 58 selective kinase inhibitor 58 sorafenib tablets 58 receptor tyrosine kinase inhibitor 58 Debio 58 investigational pharmacologically unique 58 Ixabepilone 58 Alzhemed TM 58 piperacillin tazobactam 58 OvaRex ® MAb 58 AKT inhibitor 58 DOV Pharmaceutical 58 Teriflunomide 58 selective androgen receptor modulator 58 Allovectin 7 ® 58 Syncria 58 biased ligand 58 alglucosidase alfa 58 StaphVAX R 58 Omacetaxine 58 Renvela ® 58 Telintra 58 Receptor Agonist 58 sodium glucose transporter 58 Phenoptin 58 Emezine 58 Polymer Microspheres 58 Loramyc ™ 58 Vitaxin 58 NeuroSTAT ® 58 denileukin diftitox 58 pharmacodynamic properties 58 non nucleoside inhibitor 58 oral immunomodulatory 58 small molecule glucokinase 58 6R BH4 58 Initiates Enrollment 58 Cladribine 58 LymphoStat B belimumab 58 ULTRASE 58 Fortigel 58 CardioVascular BioTherapeutics 58 Aurexis 58 Minapharm 58 XL# XL# XL# XL# 58 antisense oligonucleotide 58 AEterna 58 subcutaneous immunoglobulin 58 cancer immunotherapies 58 Factor Xa inhibitor 58 MOZOBIL 58 factor VIIa 58 Evoltra ® 58 evaluating tivozanib 58 Octreolin 58 oral cladribine 58 oral picoplatin 58 OncoVEX GM CSF 58 Pruvel 58 HCV protease inhibitors 58 cangrelor 58 TKPHF 58 refractory chronic lymphocytic 58 paliperidone palmitate 58 Raptiva ® 58 TOCOSOL Camptothecin 58 Tyzeka Sebivo 58 Teysuno 58 DEB# 58 aerosolized AAT 58 DepoDur 58 pharmacological chaperone 58 Angiotensin 58 DDP# 58 Novolimus 58 SinuNase 58 cytostatic 58 investigational antiplatelet agent 58 Celator 58 anti infective treatments 58 mapatumumab 58 Sanochemia 58 Levetiracetam 58 therapeutic monoclonal antibody 58 Panzem 58 Phase #b/#a trial 58 Decentralized Procedure 58 luliconazole 58 Solzira 58 Cimzia ® certolizumab pegol 58 5 HT3 antagonist 58 antifibrotic 58 miconazole Lauriad R 58 Emselex 58 Solulin 58 anti CD3 58 acyclovir Lauriad R 58 BiTE 58 etanercept Enbrel 58 HSP# inhibitors 58 Faropenem 58 HDACi 58 anti muscarinic 58 Adenuric ® 58 Tumour Vascular Disrupting Agent 57 humanized monoclonal antibody 57 Vernalis plc 57 growth hormone rhGH 57 sublingual tablets 57 ZALBIN 57 AMEVIVE 57 Rectogesic 57 Xyrem ® 57 PN# [001] 57 Bosutinib 57 regorafenib 57 anti EGFR antibody 57 budesonide foam 57 Ridaforolimus 57 REBETOL combination therapy 57 chronic ITP patients 57 Wellstat 57 Kyowa Kirin 57 Belerofon 57 epoetin zeta 57 Tegaserod 57 HspE7 57 MVA HPV IL2 57 intravesical instillation 57 HCV RNA polymerase 57 EndoTAG TM 57 sodium thiosulfate STS 57 Prolastin C 57 RoACTEMRA 57 Durect 57 topoisomerase II inhibitor 57 castrate resistant prostate cancer 57 panitumumab Vectibix 57 BioDelivery Sciences 57 tezampanel NGX# 57 MVA BN R 57 Actemra tocilizumab 57 Zenyaku Kogyo 57 palonosetron 57 factor TNF receptor 57 BUPHENYL 57 BCG refractory 57 ZOLINZA 57 Troxatyl 57 brand ciclesonide HFA 57 crofelemer 57 Firazyr ® 57 SNT MC# 57 Zirgan 57 DP VPA 57 Juvantia 57 interferon lambda 57 HGS# 57 entinostat 57 PREOS R 57 alpha#beta# integrin 57 Marketing Authorisation Application MAA 57 Ixempra 57 Fentanyl Taifun 57 EVIZON TM 57 APOPTONE 57 udenafil 57 MYDICAR ® 57 Ramelteon 57 secondary hyperparathyroidism 57 ALN PCS 57 Thiovir 57 Enkephalin 57 Phase III Clinical Trial 57 forodesine 57 thalidomide Thalomid 57 Nexavar sorafenib 57 Tavocept 57 LHRH antagonist 57 liver resection surgeries 57 pegylated IFN 57 Excellarate TM 57 Plenaxis TM 57 hGH CTP 57 Interferon Alpha 57 Mepact 57 Elafin 57 CCR5 antagonist 57 Velcade bortezomib 57 ALVESCO R 57 oral Janus kinase 57 Hedgehog pathway inhibitor 57 recombinant factor VIIa 57 Aclidinium 57 small molecule thrombopoietin 57 zileuton 57 Neupro R 57 CoTherix 57 ACAPODENE TM 57 Homspera TM 57 HEPLISAV TM 57 intravenous acetaminophen 57 epothilone 57 rHuPH# recombinant human 57 Prednisporin TM 57 anti CD3 antibody 57 HCV protease inhibitor 57 Ceflatonin 57 5 HT2A inverse 57 micafungin 57 Phase Ib study 57 Fc fusion protein rFVIIIFc 57 midstage clinical 57 orphan designation 57 Somatuline Autogel 57 Receives Positive Opinion 57 ALGRX 57 Zenvia ™ 57 LibiGel ® 57 IV APAP 57 Aryplase 57 hypoxia activated prodrug 57 VivaGel TM 57 Oral NKTR 57 Orphan Drug designation 57 REP# 57 OMAPRO ™ 57 Mycamine 57 hyperphenylalaninemia HPA due 57 HCV polymerase 57 AMPK activators 57 Orphan Drug designations 57 Fulvestrant 57 Blinatumomab 57 mTOR inhibitor 57 amrubicin 57 CINTREDEKIN BESUDOTOX 57 alfa 2a 57 Adventrx 57 Gammagard Liquid 57 GLASSIA 57 IMiDs ® 57 microtubule inhibitor 57 MyVax ® 57 ganciclovir 57 Angiocept 57 Ozarelix 57 FDA APPROVES 57 factor alpha TNF 57 Glufosfamide 57 efalizumab 57 Xcytrin R 57 receptor partial agonist 57 eltrombopag 57 nucleotide analog 57 NeoRecormon 57 adrenoceptor agonist 57 Initiate Clinical Trial 57 Azedra TM 57 Oncolys 57 HCV replicon 57 ondansetron hydrochloride 57 therapeutic antibody 57 Ondansetron 57 Yondelis ® 57 short acting bronchodilator 57 schizophrenia CIAS 57 TNF alpha inhibitor 57 vascular disrupting agent 57 PROMACTA 57 Tarmogen 57 romazarit 57 velaglucerase alfa 57 prucalopride 57 Tesmilifene 57 XP# XP# 57 Rhucin ® recombinant 57 THR beta agonist 57 RhuDex TM 57 LNP formulations 57 trastuzumab DM1 57 Phase IIb Trial 57 Lantus insulin 57 PTH1 57 vinca alkaloid 57 Alnylam RNAi 57 diclofenac sodium 57 alemtuzumab Campath 57 Soriatane 57 aurora kinase 57 Sudhir Agrawal D.Phil 57 memantine HCl 57 ALK inhibitor 57 dirucotide MBP# 57 GRNVAC1 57 NDA Submission 57 DAVANAT 57 Initiate Phase 57 oral nucleoside analogue 57 Darusentan 57 Liposomal 57 EOquin TM 57 Nanobody ® 57 COLAZAL ® 57 investigational oral 57 Synavive 57 Microplasmin 57 immunomodulator 57 CIMZIA TM